
|Articles|May 1, 2004
- Volume 0 0
Statins Help in Stroke Recovery
Advertisement
Stroke patients may benefit from taking statins, concluded the authors of a study reported in BMC Medicine (March 23, 2004). The researchers observed 433 ischemic stroke patients admitted to the US National Institute of Neurological Disorders and Stroke Program at Suburban Hospital in Bethesda, Md. Their study showed that 51% of the patients taking statins when admitted to the hospital were discharged with no major disability, compared with 38% of those not taking statins on arrival at the hospital.
Articles in this issue
over 22 years ago
Aging Brings Changesover 22 years ago
RxPRODUCT NEWS PROFILE: Cubicinover 22 years ago
Can You Read These Rxs?over 22 years ago
Treatment of Sexually Transmitted Diseasesover 22 years ago
Pharmacist Misappropriates Trade Secretsover 22 years ago
Topiramate May Reduce Frequency and Severity of Migraine Headachesover 22 years ago
HRT Is Linked to Breast Cancer Relapseover 22 years ago
Psoriasis May Be Treated Safely and Effectively with AdalimumabAdvertisement
Related to this article

In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.

BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.

A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.

Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.

American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.

fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.

Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
2
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
3
Semaglutide 2 mg Tied to Lower MACE Risk Than Tirzepatide Switch
4
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
5

